Andrew Tsai
Stock Analyst at Jefferies
(0)
# 5057
Out of 5,347 analysts
23
Total ratings
20.00%
Success rate
-34.74%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RCKT Rocket Pharmaceutica... | Downgrades: Hold | 29 3 | 2.51 | -0.4% | 2 | May 28, 2025 | |
AXSM Axsome Therapeutics | Initiates Coverage On: Buy | 200 | 105.16 | 90.19% | 1 | Apr 7, 2025 | |
BEKE KE Holdings | Maintains: Overweight | 19 27 | 18.47 | 46.18% | 2 | Mar 19, 2025 | |
MRNS Marinus Pharma | Downgrades: Hold | 5 1 | n/a | n/a | 1 | Oct 25, 2024 | |
SRPT Sarepta Therapeutics | Initiates Coverage On: Buy | 165 | 37.59 | 338.95% | 1 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 4 13 | 0.75 | 1633.33% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 8.26 | 323.73% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 21 | n/a | n/a | 1 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 33 | 2.58 | 1179.07% | 1 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 1 15 | 2.54 | 490.55% | 2 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 3 | 0.62 | 383.87% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 32 3 | 0.31 | 867.74% | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 7.88 | 153.81% | 1 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 70 | n/a | n/a | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | 2.31 | 1068.83% | 1 | Sep 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | n/a | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 16 23 | 28.85 | -20.28% | 1 | Jun 1, 2020 |